Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

BTIG Downgrades Ginkgo Bioworks Holdings to Sell

Author: Benzinga Newsdesk | May 15, 2024 01:02pm
BTIG analyst Mark Massaro downgrades Ginkgo Bioworks Holdings (NYSE:DNA) from Neutral to Sell.

Posted In: DNA